Graphene Investments SAS Acquires 44,600 Shares of UiPath, Inc. (NYSE:PATH)

Graphene Investments SAS grew its holdings in shares of UiPath, Inc. (NYSE:PATH) by 21.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 248,100 shares of the company’s stock after acquiring an additional 44,600 shares during the period. Graphene Investments SAS’s holdings in UiPath were worth $2,555,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Norges Bank acquired a new position in shares of UiPath in the 4th quarter worth approximately $71,191,000. Senvest Management LLC raised its stake in UiPath by 29.2% during the fourth quarter. Senvest Management LLC now owns 14,074,783 shares of the company’s stock worth $178,890,000 after buying an additional 3,180,300 shares during the last quarter. AQR Capital Management LLC lifted its holdings in UiPath by 45.3% in the fourth quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company’s stock valued at $84,209,000 after buying an additional 2,072,089 shares during the period. Jacobs Levy Equity Management Inc. boosted its position in UiPath by 35.6% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company’s stock valued at $69,385,000 after acquiring an additional 1,432,569 shares during the last quarter. Finally, Marshall Wace LLP grew its holdings in UiPath by 111.8% during the 4th quarter. Marshall Wace LLP now owns 2,456,102 shares of the company’s stock worth $31,217,000 after acquiring an additional 1,296,382 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on PATH. BMO Capital Markets lifted their price objective on UiPath from $11.50 to $15.50 and gave the stock a “market perform” rating in a research report on Friday, May 30th. Morgan Stanley raised their target price on UiPath from $12.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Monday, June 2nd. DA Davidson raised UiPath to a “hold” rating in a research note on Monday, June 9th. Canaccord Genuity Group set a $16.00 price target on UiPath and gave the stock a “buy” rating in a report on Monday, June 2nd. Finally, Mizuho lowered their price objective on shares of UiPath from $12.00 to $11.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $13.83.

UiPath Stock Up 2.5%

Shares of PATH opened at $12.79 on Friday. The business’s fifty day moving average is $12.35 and its 200 day moving average is $12.53. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93. The stock has a market cap of $6.84 billion, a P/E ratio of -106.53, a P/E/G ratio of 16.34 and a beta of 1.06.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm had revenue of $356.62 million for the quarter, compared to the consensus estimate of $332.17 million. During the same quarter in the prior year, the company posted $0.13 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. On average, analysts expect that UiPath, Inc. will post -0.17 EPS for the current year.

Insider Transactions at UiPath

In other UiPath news, CAO Hitesh Ramani sold 12,500 shares of the firm’s stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total transaction of $127,375.00. Following the transaction, the chief accounting officer now directly owns 314,891 shares in the company, valued at approximately $3,208,739.29. This trade represents a 3.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $12.55, for a total transaction of $564,750.00. Following the transaction, the chief executive officer now directly owns 5,688,376 shares in the company, valued at $71,389,118.80. This represents a 0.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 201,295 shares of company stock valued at $2,423,153 over the last three months. Corporate insiders own 23.19% of the company’s stock.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.